Letter | Published:

Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A

Naturevolume 352pages803807 (1991) | Download Citation

Subjects

Abstract

CYCLOSPORINA and FK506 inhibit T- and B-cell activation and other processes essential to an effective immune response1–3. In T lymphocytes these drugs disrupt an unknown step in the trans-mission of signals from the T-cell antigen receptor to cytokine genes that coordinate the immune response4–6. The putative intracellular receptors for FK506 and cyclosporin arecis-trans prolyl isomerases7–11. Binding of the drug inhibits isomerase activity8,10,11, but studies with other prolyl isomerase inhibitors12 and analysis of cyclosporin-resistant mutants in yeast suggest that the effects of the drug result from the formation of an inhibitory complex between the drug and isomerase13,14, and not from inhibi-tion of isomerase activity. A transcription factor, NF-AT, which is essential for early T-cell gene activation, seems to be a specific target of cyclosporin A and FK506 action because transcription directed by this protein is blocked in T cells treated with these drugs, with little or no effect on other transcription factors such as AP-1 and NF-κB (refs 15–17). Here we demonstrate that NF-AT is formed when a signal from the antigen receptor induces a pre-existing cytoplasmic subunit to translocate to the nucleus and combine with a newly synthesized nuclear subunit of NF-AT. FK506 and cyclosporin A block translocation of the cytoplasmic component without affecting synthesis of the nuclear subunit.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Borel, J. F., Feurer, C., Gubler, H. U. & Stahelin, H. Agents Actions 6, 468 (1976).

  2. 2

    Sung, S. S. et al. J. exp. Med. 168, 1539–1551 (1988).

  3. 3

    Gao, E.-K., Lo, D., Cheney, R., Kanagawa, O. & Sprent, J. Nature 336, 176–179 (1988).

  4. 4

    Crabtree, G. R. Science 243, 355–361 (1989).

  5. 5

    Schreiber, S. L. Science 251, 283–287 (1991).

  6. 6

    Hohman, R. J. & Hultsch, T. New Biol. 2, 663–672 (1990).

  7. 7

    Fischer, G. & Bang, H. Biochim. biophys. Acta 828, 39–42 (1985).

  8. 8

    Fischer, G., Wittmann-Liebold, B., Lang, K., Kiefhaber, T. & Schmid, F. X. Nature 337, 476–478 (1989).

  9. 9

    Handschumacher, R. E., Harding, M. W., Rice, J. & Drugge, R. J. Science 226, 544–547 (1984).

  10. 10

    Lang, K. & Schmid, F. X. Nature 331, 453–455 (1988).

  11. 11

    Standaert, R. F., Galat, A., Verdine, G. L. & Schreiber, S. L. Nature 346, 671–674 (1990).

  12. 12

    Bierer, B. E., Somers, P. K., Wandless, T. J., Burakoff, S. J. & Schreiber, S. L. Science 250, 556–559 (1990).

  13. 13

    Bierer, B. E. et al. Proc. natn. Acad. Sci. U.S.A. 87, 9231–9235 (1990).

  14. 14

    Tropschug, M., Barthelmess, I. B. & Neupert, W. Nature 342, 953–955 (1989).

  15. 15

    Shaw, J.-P. et al. Science 241, 202–205 (1988).

  16. 16

    Emmel, E. A. et al. Science 246, 1617–1620 (1989).

  17. 17

    Mattila, P. S. et al. EMBO J. 9, 4425–4433 (1990).

  18. 18

    Wiskocil, R., Weiss, A., Imboden, J., Kamin-Lewis, R. & Stobo, J. J. Immun. 134, 1599–1603 (1985).

  19. 19

    Fiering, S. et al. Genes Dev. 4, 1823–1834 (1990).

  20. 20

    Rosen, M. K., Standaert, R. F., Galat, A., Nakatsuka, M. & Schreiber, S. L. Science 248, 863–866 (1990).

  21. 21

    Dumont, F. J., Staruch, M. J., Koprak, S. L., Melino, M. R. & Signal, N. H. J. Immun. 144, 251–258 (1990).

  22. 22

    Dumont, F. J. et al. J. Immun. 144, 1418–1424 (1990).

  23. 23

    Karttunen, J. & Shastri, N. Proc. natn. Acad. Sci. U.S.A. 88, 3972–3976 (1991).

  24. 24

    Kay, J. E., Doe, S. E. A. & Benzie, C. R. Cell. Immun. 124, 175–181 (1989).

  25. 25

    Cirillo, R. et al. J. Immun. 144, 3891–3897 (1990).

  26. 26

    Gunter, K. C., Irving, S. G., Zipfel, P. F., Siebenlist, U. & Kelly, K. J. Immun. 142, 3286–3291 (1989).

  27. 27

    Kolestsky, A. J., Harding, M. W. & Handschumacher, R. E. J. Immun. 137, 1054–1059 (1986).

  28. 28

    Kincaid, R. L., Takayama, H., Billingsley, M. L. & Sitkovsky, M. V. Nature 330, 176–178 (1987).

  29. 29

    Tropschug, M., Wachter, E., Mayer, S., Schonbrunner, E. R. & Schmid, F. X. Nature 346, 674–677 (1990).

  30. 30

    Sieklerka, J. J., Hung, S. H. Y., Poe, M., Lin, C. S. & Sigal, N. H. Nature 341, 755–757 (1989).

  31. 31

    Harding, W. M., Galat, A., Uehling, D. E. & Schreiber, S. L. Nature 341, 758–760 (1989).

  32. 32

    Ohlsson, H. & Edlund, T. Cell 45, 35–44 (1986).

  33. 33

    Fried, M. G. & Crothers, D. M. Nucleic Acids Res. 9, 6505–6526 (1981).

  34. 34

    Garner, M. M. & Revzin, A. Nucleic Acids Res. 9, 3047–3059 (1981).

Download references

Author information

Affiliations

  1. Beckman Center for Molecular and Genetic Medicine, Howard Hughes Medical Institute, Stanford University Medical School, Stanford, California, 94305, USA

    • W. Michael Flanagan
    • , Blaise Corthésy
    • , Richard J. Bram
    •  & Gerald R. Crabtree

Authors

  1. Search for W. Michael Flanagan in:

  2. Search for Blaise Corthésy in:

  3. Search for Richard J. Bram in:

  4. Search for Gerald R. Crabtree in:

About this article

Publication history

Received

Accepted

Issue Date

DOI

https://doi.org/10.1038/352803a0

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.